Argentina eyes tech hub, boosts flights, bans risky drugs
Milei sees tech potential. Avianca plans more flights. ANMAT bans GM1 drugs due to risks. SENASA updates Norpatagonian fruit regs. ARCA offers PyMEs fine relief.
Sources (5)
- Milei ante emprendedores del país: “Argentina ha demostrado tener todo para convertirse en un polo tecnológico” ↗
President Javier Milei told entrepreneurs Argentina has "everything to become a technological hub." He cited natural resources, human capital, and the government's deregulation efforts at the Endeavor Argentina Gala. Milei emphasized technology boosts productivity and human dignity.
- Scioli se reunió con directivos de Avianca para impulsar una mayor conectividad aérea con Argentina ↗
Daniel Scioli met Avianca execs to boost flights to Argentina. Airline now flies 42 weekly flights, plans more next year. “We want to promote more tourists,” Scioli stated. Avianca sees Argentina as key.
- Se prohíben todas las especialidades medicinales que contengan Monosialogangliósidos (GM1) ↗
Argentina's ANMAT bans all medicines containing Monosialogangliósidos (GM1). The agency cited lack of proven efficacy and serious health risks, including Guillain-Barré syndrome. Products must be removed from the market within 90 days.
- Patagonia Norte: el SENASA informó los requisitos de habilitación para empaques y frigoríficos ↗
SENASA briefed 140 Norpatagonian fruit packing/refrigeration plant managers on 2026-2027 regulations. Focus on new resolutions and DTVe traceability. A follow-up session is scheduled for November 17.
- Inocencia Fiscal II: reglamentación el plan de reducción de multas para PyMEs ↗
Argentina's ARCA implements Inocencia Fiscal II, offering a 50% reduction on fines for PyMEs, non-profits, and individuals. Applies to obligations from Jan 2 to Oct 9, 2026. Deadline for compliance: Dec 18, 2026.